Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0588U
|
Infectious disease (bacterial or viral) 32 genes (29 informative and 3 housekeeping) immune response mRNA gene expression profiling by split-well multiplex reverse transcription loop-mediated isothermal amplification (RT-LAMP) whole blood reported as continuous risk scores for likelihood of bacterial and viral infection and likelihood of severe illness within the next 7 days
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0589T
|
Electronic analysis with simple programming of implanted integrated neurostimulation system (eg electrode array and receiver) including contact group(s) amplitude pulse width frequency (Hz) on/off cycling burst dose lockout patient-selectable parameters responsive neurostimulation detection algorithms closed-loop parameters and passive parameters when performed by physician or other qualified health care professional posterior tibial nerve 1-3 parameters
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0589U
|
Perfluoroalkyl substances (PFAS) (eg perfluorooctanoic acid perfluorooctane sulfonic acid) 24 PFAS compounds by high-performance liquid chromatography with tandem mass spectrometry (LC-MS/MS) plasma or serum quantitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0590T
|
Electronic analysis with complex programming of implanted integrated neurostimulation system (eg electrode array and receiver) including contact group(s) amplitude pulse width frequency (Hz) on/off cycling burst dose lockout patient-selectable parameters responsive neurostimulation detection algorithms closed-loop parameters and passive parameters when performed by physician or other qualified health care professional posterior tibial nerve 4 or more parameters
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0590U
|
Infectious disease (bacterial and fungal) DNA of 44 organisms (34 bacteria 10 fungi) urine next-generation sequencing reported as positive or negative for each organism
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0591T
|
Health and well-being coaching face-to-face; individual initial assessment
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0591U
|
Oncology (prostate cancer) biochemical analysis of 3 proteins (total PSA free PSA and HE4) plasma serum prognostic algorithm incorporating 3 proteins and digital rectal examination results reported as a probability score for clinically significant prostate cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0592T
|
Health and well-being coaching face-to-face; individual follow-up session at least 30
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0592U
|
Oncology (hematolymphoid neoplasms) DNA targeted genomic sequence of 417 genes interrogation for gene fusions translocations rearrangements utilizing formalin-fixed paraffin-embedded (FFPE) tumor tissue results report clinically significant variant(s)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0593T
|
Health and well-being coaching face-to-face; individual follow-up session at least 30 minutes
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0593U
|
Infectious disease (genitourinary pathogens) DNA 46 targets (28 pathogens 18 resistance genes) RT-PCR amplified probe technique urine each analyte reported as detected or not detected
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0594U
|
Infectious disease (sepsis) semiquantitative measurement of pancreatic stone protein concentration whole blood reported as risk of sepsis
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0595U
|
Infectious disease (tropical fever pathogens) vector-borne and zoonotic pathogens including 2 viruses (Chikungunya virus and Dengue virus serotypes 1 2 3 and 4) 1 bacterium (Leptospira species) and 1 parasite with species differentiation (Plasmodium species Plasmodium falciparum and Plasmodium vivax/ovale) real-time RT-PCR whole blood each pathogen reported as detected or not detected
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0596U
|
Neurology (Alzheimer disease) plasma 3 distinct isoform-specific peptides (APOE2 APOE3 and APOE4) by liquid chromatography with tandem mass spectrometry (LC-MS/MS) reported as an APOE prototype
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0597U
|
Oncology (breast) RNA expression profiling of 329 genes by targeted next-generation sequencing and 20 proteins by multiplex immunofluorescence formalin-fixed paraffin-embedded (FFPE) tissue algorithmic analyses to determine tumor-recurrence risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0598U
|
Gastroenterology (irritable bowel syndrome) IgG antibodies to 18 food items by microarray-based immunoassay whole blood or serum report as elevated (positive) or normal (negative) antibody levels
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0599U
|
Oncology (pancreatic cancer) multiplex immunoassay of ICAM1 TIMP1 CTSD THBS1 and CA 19-9 serum diagnostic algorithm reported as positive or negative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0600U
|
Infectious disease (wound infection) identification of 65 organisms and 30 antibiotic resistance genes wound swab real-time PCR reported as positive or negative for each organism
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0601U
|
Infectious disease (periprosthetic joint infection) analysis of 11 biomarkers (alpha defensins 1-3 C-reactive protein microbial antigens for Staphylococcus [SPA SPB] Enterococcus Candida and C. acnes total nucleated cell count percent neutrophils RBC count and absorbance at 280 nm) using immunoassays hematology clinical chemistry synovial fluid and diagnostic algorithm reported as a probability score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0602U
|
Endocrinology (diabetes) insulin (INS) gene methylation using digital droplet PCR insulin and C-peptide immunoassay serum Hemoglobin A1c immunoassay whole blood algorithm reported as diabetes-risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.